News and Views
Nature Immunology 8, 477 - 478 (2007)
doi:10.1038/ni0507-477
Smads keep TABs on inflammation
Rashu B Seth1 & Zhijian J Chen1
- Rashu B. Seth and Zhijian J. Chen are with the Howard Hughes Medical Institute and Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA. e-mail: zhijian.chen@utsouthwestern.edu
Abstract
Smad7 controls inflammation by negatively regulating activation of the transcription factor NF-
B. New work shows that Smad7 inhibits NF-
B by binding to the regulatory proteins TAB2 and TAB3, thereby blocking association of the E3 ubiquitin ligase TRAF2 with the kinase TAK1.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Signal transduction Aspirin, ubiquitin and cancerNature News and Views (14 Aug 2003)
E2 enzymes: expanding the 'ubi-verse' of immune signalingNature Immunology News and Views (01 Sep 2006)
See all 7 matches for News And ViewsRESEARCH
The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-κB signallingThe EMBO Journal Article (04 Mar 2009)
Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signalingNature Immunology Article (01 Sep 2006)
See all 39 matches for Research
